Kayyem Jon Faiz 13D/13G Filings for Inhibrx Biosciences, Inc. (INBX)

Kayyem Jon Faiz 13D and 13G filings for Inhibrx Biosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-02-26
4:26 pm
Purchase		 2024-06-03 13D Inhibrx Biosciences, Inc.
INBX		 Kayyem Jon Faiz 1,149,046
7.900%		 330,471increase
(+40.37%)		 Filing
2024-06-03
8:45 pm
Purchase		 2024-05-29 13D Inhibrx Biosciences, Inc.
INBX		 Kayyem Jon Faiz 818,575
5.650%		 818,575increase
(New Position)		 Filing